{{featured_button_text}}
Beaver Dam man in the defendants chair for week long reckless homicide trial

Brian K. Larson, left, of Beaver Dam, is shown with his attorney, John Smerlinski, at the start of his reckless homicide trial on Monday in Dodge County Circuit Court. 

JUNEAU — A trial for a 29-year-old Beaver Dam man charged with reckless homicide began Monday morning.

Brian K. Larson is accused of delivering the fatal dose of heroin to Dakoda Kline, a 25-year-old from Juneau, in April 2017. Kline was found dead in a running vehicle in a cemetery in Beaver Dam.

Larson is charged with felony counts of reckless homicide by way of delivering a controlled substance, two counts of manufacturing or delivering heroin and two counts of bail jumping in January. If convicted of all the charges, he could be sentenced to up to 77 years in prison and receive up to $170,000 in fines.

The courtroom of Dodge County Circuit Court Judge Martin De Vries took the morning to narrow a jury down from 33 potential jurors to the 15 who will hear the case.

Assistant District Attorney Yolanda Tienstra described Kline as having some good and bad points in his life. At the time of his death, he was engaged and had two children. She noted a horrible car crash led to an addiction to prescription drugs. When he could no longer obtain the prescription drugs, he turned to heroin.

Attorneys made opening statements and the first few witnesses for the prosecution testified after the jury was selected.

According to the criminal complaint, the Dodge County Sheriff’s Office secured a warrant for both Larson and Kline’s phone records and found that the two had exchanged text messages about drugs. The complaint says their phone activity coincided with ATM cash withdrawals Kline made and a trip Larson made to Milwaukee.

The complaint says that a text Larson sent to Kline about “really good stuff” was sent when their phones pinged to the same area in Beaver Dam.

Follow Terri Pederson on Twitter @tlp53916 or contact her at 920-356-6760.

(0) comments

Welcome to the discussion.

We welcome reader interaction. What are your questions about this article? Do you have an idea to share? Please stick to the topic and maintain a respectful attitude toward other participants. (You can help: Use the 'Report' link to let us know of off-topic or offensive posts.)